Loading...
Phase II open label study of valproic acid in spinal muscular atrophy.
UNLABELLED:Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to as...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2680034?pdf=render |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|